Business
Guardant Health to Participate in Upcoming November Investor Conferences
PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate
About this update from Guardant Health, Inc.
[{"type":"text","content":" PALO ALTO, Calif.--(BUSINESS WIRE)--\nGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will participate in the following investor conferences:\n\n\n\nJefferies 14th Annual Global Healthcare Conference in London, UK\nPresentation on Thursday, November 16 at 9:00 a.m. Greenwich Mean Time\n\n\n\n\nPiper Sandler 35th Annual Healthcare Conference in New York, NY\nFireside Chat on Tuesday, November 28 at 9:30 a.m. Eastern Time\n\n\n\nInterested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at: www.guardanthealth.com.\n\n\nAbout Guardant Health\n\n\nGuardant Health is a leading precision oncology company focused on helping every person live a life free from cancer. Founded in 2012, Guardant is transforming cancer care by providing critical insights into what drives the disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve patient outcomes across all stages of cancer, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn and X (Twitter).\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20231103008804/en/\n\nInvestor Contact:\[email protected]\n\n\nMedia Contact:\nMelissa Morasco\[email protected]\n+1 650-647-3711\n\n\nSource: Guardant Health, Inc.","length":3865,"tagName":"div"}]